Publication by Christian Kurzeder et al.: Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial.

Kurzeder et al. demonstrate in a proof-of-concept study that digoxin, an Na+/K+ ATPase inhibitor, reduces circulating tumor cell clusters in metastatic breast cancer patients, supporting further studies with refined inhibitors and clinical endpoints.